Core Cap Advisors, LLC Acer Therapeutics Inc. Transaction History

Core Cap Advisors, LLC

  • $917 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
SELL
$1.98 - $2.98 $190 - $286
-96 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$1.88 - $2.9 $180 - $278
96 New
96 $1,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email